Cardiologia - i registri TAVI

TAVI: registriTAVI: trial randomizzati (PARTNER)Valvole percutaneeTAVI: sopravvivenzaTAVI: effetto su mortalitàEfficacia TAVI su classe NYHAEfficacia TAVI su classe NYHAValvole percutanee: protesi su protesiEur Heart J 2011;32:140–147J Am Coll Cardiol 2010;55:97–101Circulation 2010;121:1848–1857Complicanze: strokeMain outcomes in mortality and stroke in the PARTNER trial after 30 days and 1 year of follow-up. A: cohort A, patients at high surgical risk who underwentpercutaneous transcatheter aortic valve implantation versus aortic valve replacement surgery. B: cohort A, candidates for percutaneous transcatheter aortic valveimplantation via the transfemoral approach versus aortic valve replacement surgery. C: cohort A, patients in whom percutaneous transthoracic aortic valveimplantation via transfemoral access was not possible, who were treated using the transapical approach, versus aortic valve replacement surgery. D: cohort B,inoperable patients who underwent

Il confronto tra la sostituzione valvolare aortica (AVR) e l'impianto valvolare aortico percutaneo transcateretere (TAVI) è stato oggetto di studio.